mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.2 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.083 |
0.2 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |